Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures
NCT02705768Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carbamazepine and oxcarbazepine in focal seizures (3 arms), sponsored by AIIMS New Delhi. Primary endpoints: Serum neuron-specific enolase at 4 weeks and Serum S100B at 4 weeks. Started Apr 2016; status: completed.
02
Drugs
carbamazepineoxcarbazepine
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT02705768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705768.